Curriculum vitae
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers | PLOS ONE
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Mitarbeiter des Rudolf-Boehm-Institutes
Type of the Paper (Article
Loop | Achim Aigner
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's D
Evaluation of Colon-Specific Plasma Nanovesicles as New Markers of Colorectal Cancer
European Technology Platform on Nanomedicine
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Focused Ultrasound Therapy
SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC) | Scientific Reports
Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Therapeutic siRNA: State-of-the-Art and Future Perspectives | SpringerLink
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Zeitschrift für Naturforschung C
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
PEI-complexed LNA antiseeds as miRNA inhibitors
Mitarbeiter des Rudolf-Boehm-Institutes
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 - ChemMedChem - Wiley Online Library
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
